Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00017004 · ClinicalTrials.gov registry record · Phase 3
Radiation Therapy and Cisplatin With or Without Epoetin Alfa in Treating Patients With Cervical Cancer and Anemia
A Phase 3 study, sponsored by Gynecologic Oncology Group.
- Completed
- Registry status
- Phase 3
- Development phase
- 114
- Enrollment target
NCT00017004 is a Phase 3 study that has completed, run by Gynecologic Oncology Group. The registered enrollment target is 114 participants.
The verdict
NCT00017004, a Phase 3 study, has completed, sponsored by Gynecologic Oncology Group.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 114 participants
- Enrollment target
Study Summary
Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Radiation therapy uses high-energy x-rays to damage tumor cells. Epoetin alfa may stimulate red blood cell production to treat anemia in patients who have received chemotherapy and/or radiation therapy for cervical cancer. Randomized phase III trial to study the effectiveness of epoetin alfa in treating anemia in patients who have cervical cancer.
Interventions
- DRUG Cisplatin
- RADIATION External Beam Radiation Therapy
- BIOLOGICAL Epoetin Alfa
- RADIATION Internal Radiation Therapy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 114 participants |
| Start Date | 2001-08 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00017004
The ClinicalTrials.gov registry entry for NCT00017004 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 114 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Gynecologic Oncology Group, which has 154 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 4 interventions - of which Cisplatin is the first listed.
NCT00017004 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00017004 about?
NCT00017004 is a clinical study titled "Radiation Therapy and Cisplatin With or Without Epoetin Alfa in Treating Patients With Cervical Cancer and Anemia". Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Radiation therapy uses high-energy x-rays to damage tumor cells. Epoetin alfa may stimulate red blood cell production to treat anemia in patients who have received chemotherapy and/or radiati...
What is the current status of trial NCT00017004?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 114 participants. The study started on 2001-08.
What interventions are being tested in trial NCT00017004?
The interventions under investigation include: Cisplatin (DRUG), External Beam Radiation Therapy (RADIATION), Epoetin Alfa (BIOLOGICAL), Internal Radiation Therapy (RADIATION).
Who is sponsoring clinical trial NCT00017004?
This trial is sponsored by Gynecologic Oncology Group, which has 154 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.